Xie N - Search Results

1

siRNA-Mediated Suppression of Synuclein γ Inhibits MDA-MB-231 Cell Migration and Proliferation by Downregulating the Phosphorylation of AKT and ERK.

He J, Xie N, Yang J, Guan H, Chen W, Wu H, Yuan Z, Wang K, Li G, Sun J, Yu L. He J, et al. Among authors: xie n. J Breast Cancer. 2014 Sep;17(3):200-6. doi: 10.4048/jbc.2014.17.3.200. Epub 2014 Sep 30. J Breast Cancer. 2014. PMID: 25320617 Free PMC article.

2

miRNA-411 acts as a potential tumor suppressor miRNA via the downregulation of specificity protein 1 in breast cancer.

Guo L, Yuan J, Xie N, Wu H, Chen W, Song S, Wang X. Guo L, et al. Among authors: xie n. Mol Med Rep. 2016 Oct;14(4):2975-82. doi: 10.3892/mmr.2016.5645. Epub 2016 Aug 19. Mol Med Rep. 2016. PMID: 27572271 Free PMC article.

3

BCSG1 siRNA delivered by lentiviral vector suppressed proliferation and migration of MDA-MB-231 cells.

He JS, Xie N, Yang JB, Guan H, Chen WC, Zou C, Ouyang YW, Mao YS, Luo XY, Pan Y, Fu L. He JS, et al. Among authors: xie n. Int J Mol Med. 2018 Mar;41(3):1659-1664. doi: 10.3892/ijmm.2017.3355. Epub 2017 Dec 29. Int J Mol Med. 2018. PMID: 29286089

4

Identification of GZMA as a Potential Therapeutic Target Involved in Immune Infiltration in Breast Cancer by Integrated Bioinformatical Analysis.

Huo Q, Ning L, Xie N. Huo Q, et al. Among authors: xie n. Breast Cancer (Dove Med Press). 2023 Mar 10;15:213-226. doi: 10.2147/BCTT.S400808. eCollection 2023. Breast Cancer (Dove Med Press). 2023. PMID: 36926265 Free PMC article.

5

Hypoxia-inducible factor 1 mediates intermittent hypoxia-induced migration of human breast cancer MDA-MB-231 cells.

Liu L, Liu W, Wang L, Zhu T, Zhong J, Xie N. Liu L, et al. Among authors: xie n. Oncol Lett. 2017 Dec;14(6):7715-7722. doi: 10.3892/ol.2017.7223. Epub 2017 Oct 19. Oncol Lett. 2017. PMID: 29250173 Free PMC article.

6

ERRα is an aggressive factor in lung adenocarcinoma indicating poor prognostic outcomes.

Li P, Wang J, Wu D, Ren X, Wu W, Zuo R, Zeng Q, Wang B, He X, Yuan J, Xie N. Li P, et al. Among authors: xie n. Cancer Manag Res. 2019 Sep 2;11:8111-8123. doi: 10.2147/CMAR.S204732. eCollection 2019. Cancer Manag Res. 2019. PMID: 31564971 Free PMC article.

7

SCUBE3 serves as an independent poor prognostic factor in breast cancer.

Huo Q, He X, Li Z, Yang F, He S, Shao L, Hu Y, Chen S, Xie N. Huo Q, et al. Among authors: xie n. Cancer Cell Int. 2021 May 18;21(1):268. doi: 10.1186/s12935-021-01947-3. Cancer Cell Int. 2021. PMID: 34006286 Free PMC article.

8

VWCE as a potential biomarker associated with immune infiltrates in breast cancer.

Huo Q, Li Z, Chen S, Wang J, Li J, Xie N. Huo Q, et al. Among authors: xie n. Cancer Cell Int. 2021 May 21;21(1):272. doi: 10.1186/s12935-021-01955-3. Cancer Cell Int. 2021. PMID: 34020650 Free PMC article.

9

Predictive and Prognostic Value of TRIM58 Protein Expression in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy.

Zheng YZ, Li JY, Ning LW, Xie N. Zheng YZ, et al. Among authors: xie n. Breast Cancer (Dove Med Press). 2022 Dec 21;14:475-487. doi: 10.2147/BCTT.S387209. eCollection 2022. Breast Cancer (Dove Med Press). 2022. PMID: 36578908 Free PMC article.

10

High HSPB1 expression predicts poor clinical outcomes and correlates with breast cancer metastasis.

Huo Q, Wang J, Xie N. Huo Q, et al. Among authors: xie n. BMC Cancer. 2023 Jun 3;23(1):501. doi: 10.1186/s12885-023-10983-3. BMC Cancer. 2023. PMID: 37268925 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,481 results

Search Page

Filters